Celltrion Healthcare has decided to buy 25 billion worth of treasury stock

Reporter Kim Jisun / approved : 2023-07-07 03:00:30
  • -
  • +
  • 인쇄

 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Celltrion Healthcare held a board meeting today (6th) in accordance with Celltrion Group's shareholder value enhancement management principle and decided to buy back its shares.

Celltrion Healthcare will buy a total of 380,000 shares, which is expected to be acquired about 25 billion won.

Treasury stock will be acquired through in-house purchase from July 7 to October 6, 2023.

As a result, Celltrion Healthcare has decided to buy back its shares for the third time this year after February and March, and will acquire a total of 1.215 million shares worth about 75 billion won this year alone.

Meanwhile, its affiliate Celltrion also decided to acquire about 200 billion won on four occasions this year, announcing the purchase of additional shares worth about 50 billion won on the 5th.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

HEADLINE

건강이 보이는 대표 K Medical 뉴스

PHOTO

많이 본 기사